Industry Analysis
Micron’s current valuation has priced in excessive optimism around the AI supercycle. While its HBM3E benefits from AI cluster expansion, aggressive DRAM capacity additions risk a price correction by 2027. Technologically, tighter integration with TSMC’s (Taiwan, China) CoWoS packaging increases supply chain concentration risk. Compliance-wise, U.S. CHIPS Act “guardrails” restrict Micron’s China mainland investments, forcing higher-cost expansions in the U.S. or India. Though not direct rivals, Intel and NXP are adopting chiplet architectures to reduce reliance on single HBM suppliers, eroding Micron’s pricing power. Over the next 12–24 months, any shortfall in NVIDIA GB200 deployment or hyperscaler capex cuts will hit Micron first—likely triggering inventory corrections and margin compression, pushing shares toward a $400 support level.
This page displays AI-generated summaries and metadata for research purposes. Original content belongs to the respective publishers.